combretastatin has been researched along with Pancreatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coy, DH; Franko-Tobin, LG; Fuselier, JA; LePage, KT; Leslie, JS; Luo, J; Mackey, LV; Morris, LM; Sun, L | 1 |
1 other study(ies) available for combretastatin and Pancreatic Neoplasms
Article | Year |
---|---|
Application of human pancreatic carcinoid BON cells for receptor-targeted drug development.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bibenzyls; Bombesin; Camptothecin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Drug Design; Humans; Ligands; Mice; Mice, Nude; Molecular Targeted Therapy; Pancreatic Neoplasms; Protein Binding; Real-Time Polymerase Chain Reaction; Receptors, Bombesin; Receptors, Cell Surface; Receptors, Somatostatin; Somatostatin; Xenograft Model Antitumor Assays | 2011 |